Dermavant CEO draws Botox comparison to instill Vtama confidence amid slow psoriasis uptake
Fierce Pharma
NOVEMBER 28, 2023
Dermavant CEO Todd Zavodnick isn’t concerned with the slow uptake of the hyped plaque psoriasis drug Vtama. He points to another breakthrough treatment which took a while to catch on: Botox. Dermavant CEO Todd Zavodnick isn’t concerned with the slow uptake of hyped plaque psoriasis drug Vtama.
Let's personalize your content